Advancements in Individualized Drug Formulations

The advent of personalized medicine (PM) has catalyzed a shift from traditional “one-size-fits-all” approaches to individualized therapeutic strategies that address genetic, physiological, and lifestyle differences among patients. Fixed-dose pharmaceutical products often fail to meet the diverse needs of patient populations, resulting in significant adverse effects and suboptimal outcomes. Innovations such as 3D printing technologies offer transformative solutions by enabling rapid, cost-effective, and tailored drug formulations. Key advances include complex drug delivery systems, pharmacogenomics integration, patient-centric design, and emerging concepts like 4D printing. Despite substantial progress, significant regulatory, ethical, and economic challenges remain. Personalized drug formulation holds immense potential for improving treatment adherence, efficacy, and healthcare economics, but requires careful navigation of technical, ethical, and regulatory landscapes to ensure equitable access and patient safety. The future of individualized drug therapy lies in interdisciplinary collaboration, technological innovation, and dynamic regulatory frameworks that support on-demand, patient-specific treatments. Keywords: Personalized Medicine; 3D Printing; Individualized Drug Formulation; Pharmacogenomics; Fixed-Dose Combinations; Patient-Centric Design